Table 1.
General characteristics of the subjects and primary and secondary outcomes by CR and PR.
| Characteristic | CR (n = 11) |
PR (n = 10) |
Difference between CR and PR Effect |
p-Value for Difference between CR and PR Effect |
|---|---|---|---|---|
| Age, mean (SD), y | 49 (8.5) | 51.6 (8.9) | 2.6 | 0.52 |
| Female, no. (%) | 7 (63) | 5 (50) | 2 | - |
| T2DM diagnostic, mean (SD), y | 9 (1.3) | 8 (1.4) | 1 | 0.24 |
| Height, mean (SD), m | 1.64 (0.08) | 1.65 (0.08) | −0.01 | 0.96 |
| Primary Outcomes | ||||
| Δ Fasting glucose, mean (SD), mmol/L | −8.3 (3.0) | −7.0 (3.6) | 1.3 | 0.20 |
| Δ Hemoglobin A1c, mean (SD), mmol/mol | −17.5 (7.9) | −9.2 (6.5) | 8.3 | 0.02 |
| Δ Hemoglobin A1c, mean (SD), % | −1.6 (0.7) | −0.85 (0.6) | 0.75 | 0.02 |
| Δ Weight loss, mean (SD), Kg | −6.9 (1.9) | −5.4 (3.6) | 1.5 | 0.12 |
| Weight loss, mean (SD), % | 8 (2.1) | 6.6 (4.5) | 1.4 | 0.29 |
| Secondary Outcomes | ||||
| Δ Cholesterol, mmol/L | −2.2 (1.0) | −1.9 (1.3) | 0.3 | 0.33 |
| Δ LDL cholesterol, mmol/L | −1.4 (0.6) | −1.2 (0.7) | 0.2 | 0.29 |
| Δ HDL cholesterol, mmol/L | −0.2 (0.2) | −0.2 (0.2) | 0 | 0.48 |
| Δ Triglycerides, mmol/L | −1.5 (0.8) | −0.9 (0.7) | 0.6 | 0.03 |
| Δ BP Systolic, mmHg | −46.4 (25) | −44.6 (24) | 1.8 | 0.38 |
| Δ BP Diastolic, mmHg | −57.3 (31) | −58.5 (31) | −1.2 | 0.42 |